- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7076 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
Patent holdings for IPC class A61K 31/7076
Total number of patents in this class: 2114
10-year publication summary
|
174
|
169
|
156
|
184
|
190
|
215
|
214
|
175
|
149
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Iovance Biotherapeutics, Inc. | 317 |
63 |
| Atea Pharmaceuticals, Inc. | 67 |
41 |
| Epizyme, Inc. | 386 |
31 |
| Can-fite Biopharma Ltd. | 57 |
28 |
| Chiesi Farmaceutici S.p.A. | 958 |
27 |
| Gilead Sciences, Inc. | 1951 |
27 |
| The Board of Regents of the University of Texas System | 2132 |
25 |
| The Regents of the University of California | 19517 |
24 |
| Merck Sharp & Dohme LLC | 3751 |
23 |
| Future Medicine Co., Ltd. | 37 |
20 |
| Alios BioPharma, Inc. | 67 |
19 |
| Emory University | 1588 |
19 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2838 |
19 |
| University Health Network | 1018 |
18 |
| University of South Florida | 1827 |
16 |
| The Johns Hopkins University | 5533 |
15 |
| Arcus Biosciences, Inc. | 122 |
14 |
| Dana-Farber Cancer Institute, Inc. | 2535 |
14 |
| Pharmacyclics LLC | 241 |
14 |
| Board of Regents, The University of Texas System | 5619 |
13 |
| Other owners | 1644 |